default author photo

Vanesa Gutiérrez Calderón

Hospital Regional Universitario de Málaga

Carlos de Haya Av., s/n, 29001

Málaga

Spain

SCHOLARLY PAPERS

1

DOWNLOADS

42

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Randomized phase II trial of nivolumab plus paclitaxel in subjects with recurrent/metastatic head and neck squamous cell carcinoma unable for cisplatin-based chemotherapy. NIVOTAX TTCC study

Number of pages: 22 Posted: 15 Jan 2026
Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, affiliation not provided to SSRN, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, affiliation not provided to SSRN, Hospital Clinico San Carlos, affiliation not provided to SSRN, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, Hospital Universitario de Navarra, affiliation not provided to SSRN, Hospital Regional Universitario de Málaga, affiliation not provided to SSRN, Hospital Duran i Reynals (ICO) - Catalan Institute of Oncology, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Complejo Hospitalario Universitario de Toledo, affiliation not provided to SSRN, Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitari i Politècnic La Fe, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Autonomous University of Barcelona - Medical Oncology Department
Downloads 42 (1,183,237)

Abstract:

Loading...

Head and neck, squamous cell carcinoma, unfit, frail, chemotherapy, immunotherapy